Xiu Yu

1.6k total citations · 1 hit paper
11 papers, 839 citations indexed

About

Xiu Yu is a scholar working on Molecular Biology, Hepatology and Infectious Diseases. According to data from OpenAlex, Xiu Yu has authored 11 papers receiving a total of 839 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 4 papers in Hepatology and 3 papers in Infectious Diseases. Recurrent topics in Xiu Yu's work include Hepatitis C virus research (4 papers), Biochemical and Molecular Research (3 papers) and Epigenetics and DNA Methylation (2 papers). Xiu Yu is often cited by papers focused on Hepatitis C virus research (4 papers), Biochemical and Molecular Research (3 papers) and Epigenetics and DNA Methylation (2 papers). Xiu Yu collaborates with scholars based in United States. Xiu Yu's co-authors include Wade Diehl, Rose Ann Ferre, You-Ai He, Hans E. Parge, Karen A. Maegley, Shella A. Fuhrman, Ping Chen, James Solowiej, Meirong Xu and Nathan V. Lee and has published in prestigious journals such as Nature Communications, PLoS ONE and Journal of Virology.

In The Last Decade

Xiu Yu

11 papers receiving 814 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Spectrum and Degree of CDK Drug Interactions Predicts Clinical Performance

2016 307 citations Ping Chen, Nathan V. Lee et al. Molecular Cancer Therapeutics profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Xiu Yu United States	9	346	226	217	212	185	11	839
Wade Diehl United States	9	367 1.1×	137 0.6×	260 1.2×	234 1.1×	112 0.6×	12	843
Oleg Brodsky United States	6	236 0.7×	172 0.8×	104 0.5×	65 0.3×	58 0.3×	7	438
Alexander Kurtenbach Germany	5	401 1.2×	114 0.5×	133 0.6×	46 0.2×	39 0.2×	5	664
W.W. Prosise United States	9	426 1.2×	323 1.4×	138 0.6×	28 0.1×	149 0.8×	13	909
I. Wayne Cheney United States	12	410 1.2×	90 0.4×	134 0.6×	19 0.1×	117 0.6×	15	752
Terry Robins United States	11	458 1.3×	95 0.4×	137 0.6×	68 0.3×	51 0.3×	15	848
Victoria B. Knick United States	9	434 1.3×	21 0.1×	290 1.3×	232 1.1×	108 0.6×	10	833
Smitha Kota United States	14	275 0.8×	73 0.3×	142 0.7×	32 0.2×	61 0.3×	18	630
Marc Nasoff United States	16	638 1.8×	441 2.0×	179 0.8×	58 0.3×	39 0.2×	34	1.4k
Leanne Cartee United States	14	357 1.0×	32 0.1×	226 1.0×	99 0.5×	94 0.5×	27	646

Countries citing papers authored by Xiu Yu

Since Specialization

Citations

This map shows the geographic impact of Xiu Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiu Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiu Yu more than expected).

Fields of papers citing papers by Xiu Yu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiu Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiu Yu. The network helps show where Xiu Yu may publish in the future.

Co-authorship network of co-authors of Xiu Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Xiu Yu. A scholar is included among the top collaborators of Xiu Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiu Yu. Xiu Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

1.

Chen, Ping, Nathan V. Lee, Wenyue Hu, et al.. (2016). Spectrum and Degree of CDK Drug Interactions Predicts Clinical Performance. Molecular Cancer Therapeutics. 15(10). 2273–2281. 307 indexed citations breakdown →

2.

Brooun, Alexei, K.S. Gajiwala, Ya‐Li Deng, et al.. (2016). Polycomb repressive complex 2 structure with inhibitor reveals a mechanism of activation and drug resistance. Nature Communications. 7(1). 11384–11384. 117 indexed citations

3.

Kung, Pei‐Pei, Buwen Huang, Luke R. Zehnder, et al.. (2015). SAH derived potent and selective EZH2 inhibitors. Bioorganic & Medicinal Chemistry Letters. 25(7). 1532–1537. 18 indexed citations

4.

Gajiwala, K.S., Karen A. Maegley, Rose Ann Ferre, You-Ai He, & Xiu Yu. (2013). Ack1: Activation and Regulation by Allostery. PLoS ONE. 8(1). e53994–e53994. 21 indexed citations

5.

Wang, Yongbin, et al.. (2011). Effect of compensation doping on the electrical and optical properties of mid-infrared type-II InAs/GaSb superlattice photodetectors. Chinese Physics B. 20(6). 67302–67302. 4 indexed citations

6.

Zhang, Hui‐Min, Xiu Yu, Michael J. Greig, et al.. (2010). Drug binding and resistance mechanism of KIT tyrosine kinase revealed by hydrogen/deuterium exchange FTICR mass spectrometry. Protein Science. 19(4). 703–715. 20 indexed citations

7.

Li, Hui, John Tatlock, Angelica Linton, et al.. (2009). Discovery of (R)-6-Cyclopentyl-6-(2-(2,6-diethylpyridin-4-yl)ethyl)-3-((5,7-dimethyl-[1,2,4]triazolo[1,5-a]pyrimidin-2-yl)methyl)-4-hydroxy-5,6-dihydropyran-2-one (PF-00868554) as a Potent and Orally Available Hepatitis C Virus Polymerase Inhibitor. Journal of Medicinal Chemistry. 52(5). 1255–1258. 93 indexed citations

8.

Shi, Stephanie T., Shella A. Fuhrman, Hans E. Parge, et al.. (2007). In Vitro Resistance Study of AG-021541, a Novel Nonnucleoside Inhibitor of the Hepatitis C Virus RNA-Dependent RNA Polymerase. Antimicrobial Agents and Chemotherapy. 52(2). 675–683. 39 indexed citations

9.

Love, Robert A., Karen A. Maegley, Xiu Yu, et al.. (2004). The Crystal Structure of the RNA-Dependent RNA Polymerase from Human Rhinovirus. Structure. 12(8). 1533–1544. 87 indexed citations

10.

Love, Robert A., Hans E. Parge, Xiu Yu, et al.. (2003). Crystallographic Identification of a Noncompetitive Inhibitor Binding Site on the Hepatitis C Virus NS5B RNA Polymerase Enzyme. Journal of Virology. 77(18). 10176–10176. 7 indexed citations

11.

Love, Robert A., Hans E. Parge, Xiu Yu, et al.. (2003). Crystallographic Identification of a Noncompetitive Inhibitor Binding Site on the Hepatitis C Virus NS5B RNA Polymerase Enzyme. Journal of Virology. 77(13). 7575–7581. 126 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact